跳至主要内容
临床试验/NCT03642275
NCT03642275已完成不适用

iCardia4HF: A Patient-centered Mobile Health Intervention to Promote Self-care and Improve Patient Outcomes in Chronic Heart Failure

University of Illinois at Chicago2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2019年1月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
2
主要终点
Change from Baseline in Self-care at 30 and 60 days

研究概览

简要总结

Approximately 6.5 million people have heart failure (HF) in the United States, and 960,000 new cases are reported each year. HF is one of the most common hospital diagnosis among older adults. About 40% of patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 80% of the costs of HF management. This pilot study aims to assess the feasibility, acceptability, and preliminary efficacy of a patient-centered mobile health (mHealth) technology intervention in older adults with chronic heart failure.

详细描述

This is a single site, two-arm, pilot randomized controlled trial that aims to examine the feasibility, acceptability and preliminary efficacy of a mobile phone-based intervention compared to usual care in older adult patients with HF (≥50 years). Forty (n=40) patients from the University of Illinois Hospital & Health Sciences system will be enrolled in the study, randomly assigned to the intervention or usual care group, and followed for 60 days. Patients in the intervention group will receive the Heart Failure Health Storylines mobile app developed by Self Care Catalysts in collaboration with the Heart Failure Society of America, three connected health devices from Fitbit and Nokia that interface with the mobile app, and tailored text-messages targeting health beliefs, self-care efficacy, and knowledge about HF. The control group will receive standard care which involves patient education and outpatient follow up with physical and laboratory examinations as needed. The primary study outcome is change in self-care and quality of life. Secondary outcomes include hospital re-admissions and emergency room visits.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessors will be blinded to patients' randomization assignment

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatients or outpatients with a diagnosis of HF as defined by the International Classification of Diseases (ICD-10) codes
  • Stage C, NYHA I, II or III
  • ≥ 40 years of age
  • Own a smartphone with text-messaging and internet plan
  • Ability to speak and read English
  • Live within 30 miles from UI Health

排除标准

  • On an active waiting list for implanted ventricular assist device or heart transplant
  • Advanced renal disease (dialysis or creatinine >4.0mg/dL)
  • End-stage HF (hospice candidate)
  • Active cancer
  • Individuals who are not their own primary caregiver
  • Discharge to a setting other than home
  • Patients with baseline Montreal Cognitive Assessment (MoCA) score of < 22

结局指标

主要结局

Change from Baseline in Self-care at 30 and 60 days

时间窗: Baseline, 30 and 60 days

Self-care will be measured with the Self-Care Heart Failure Index (SCHFI) v.6.2,87 which includes 3 subscales: self-care maintenance (10-items), self-care confidence (6-items), and self-care management (6-items). Standardized scores in each scale range from 0 to 100. A total score of ≥70 indicates adequate self-care.

Change from Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 days

时间窗: Baseline, 30 and 60 days

HRQoL will be measured with the Kansas City Cardiomyopathy Questionnaire (23-items) that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. Lower scores indicate worse HRQoL.

次要结局

  • Hospitalizations(60 days)
  • ER visits(60 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Spyros Kitsiou

Assistant Professor

University of Illinois at Chicago

研究点 (2)

Loading locations...

相似试验